预印本 · 体外 / 类器官研究
工程化mRNA纳米结构通过可编程蛋白表达和免疫刺激拓展mRNA疗法设计空间
Engineered mRNA nanostructures expand the design space of mRNA therapeutics through programmable protein expression and immune stimulation
作者:Mark D Knappenberger, Skylar J W Henry, Archana Kikla, Matthew Sample, Olivia Roy, Erik Poppleton, Nicholas Stephanopoulos, Michael P Gustafson, Karen S Anderson, Petr Šulc
bioRxiv · 2026年9月17日 · Knappenberger 等 10 位作者
不需要生物学背景,多打比方
正在获取全文并生成讲解(拿不到全文就依据摘要),大约需要 30–60 秒…
已等待 0 秒
这篇还没有动画
动画会把研究的流程、作用机制和关键结果一步一步演示出来,每一步都标明出自原文哪里。制作大约需要 30–60 秒。
摘要Abstract
Messenger RNA (mRNA) therapeutics have transformed vaccination and protein replacement strategies, yet efforts to improve their performance have focused largely on sequence engineering, nucleotide modification, and delivery vehicles. Here we show that mRNA function can be controlled by rational design of higher-order RNA architectures. We develop self-assembling mRNA origami (mRNA-OG), a class of unimolecular RNA nanostructures that encode protein-coding sequences within higher-order, programmable, and compact nucleic acid architectures. Using computational design and experimental validation, we demonstrate that mRNA-OG folds into well-defined nanostructures while remaining translationally competent in mammalian cells. Although folded mRNA-OG recruits ribosomes comparably to unfolded constructs, it produces lower protein output, indicating that RNA architecture can directly influence translational efficiency. The compact geometry of mRNA-OG also enhances encapsulation by cationic lipid delivery systems, suggesting a structural route to improved cargo packaging. Beyond its effects on translation, mRNA architecture modulates innate immune recognition. In primary human dendritic cells, folded and unfolded mRNA-OG elicit distinct cytokine programs and differential activation of stress-response pathways, including a modest induction of the integrated stress response that is not fully explained by canonical PKR signaling. Our results establish programmable structure as a new design parameter for mRNA therapeutics that can affect its functionality, delivery properties, and immune sensing.
还没有查过关联研究
我会去找这篇研究之前的基础工作、做类似事情的研究,以及之后引用它的研究,并说明每篇为什么相关。